This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

API probe in China's Tianjin fines four companies, five individuals for price fixing

( June 16, 2025, 04:41 GMT | Official Statement) -- MLex Summary: China's Tianjin antitrust regulator fined and confiscated illegal gains from four companies and five individuals for price fixing, with penalties totaling 362 million yuan ($51 million), according to penalty decisions issued by the State Administration for Market Regulation. Four executives, each from a different drugmaker — Zhejiang Xianju Pharmaceutical, Jinyao Pharmaceutical, Xi’an Guokang Ruijin Pharmaceutical, and Lianhuan Pharmaceutical — were each fined 600,000 yuan for their role in fixing the prices of the active pharmaceutical ingredient dexamethasone sodium phosphate. In addition, Guo Xiangguo, identified as a key individual in orchestrating the cartel agreement, was fined 5 million yuan.The statement follows and the penalty decisions are attached:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login